drugset / Trial / NCT00668317

Bronchial Hyper-responsiveness in Reflux Cough

NCT00668317

Phase 3 Terminated 5 enrolled Hull University Teaching Hospitals NHS Trust
NaSingle-groupOpen-labelHealth-services research

Summary

The study aim is to determine the effect of 8 weeks of anti-reflux treatment (full acid suppression) on bronchial hyper-responsiveness and whether there is a symptomatic improvement.

Timeline

Start
2006-09
Primary completion
2009-09
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 20 mg Oral
Subject Ranitidine Unknown 300 mg Oral

Indications

No indication recorded.